A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Seagen Inc.
Novartis
Arcus Biosciences, Inc.
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
Pfizer
Astellas Pharma Inc
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Pfizer
Baylor Research Institute
University of Miami
Genentech, Inc.
Pfizer
Eli Lilly and Company
Mayo Clinic
City of Hope Medical Center
Massachusetts General Hospital
Enliven Therapeutics
Massachusetts General Hospital
The Methodist Hospital Research Institute
Cancer Trials Ireland
University Health Network, Toronto
City of Hope Medical Center
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Tanta University
Hansoh BioMedical R&D Company
Ohio State University Comprehensive Cancer Center
Ono Pharmaceutical Co. Ltd
Ohio State University Comprehensive Cancer Center
Merck Sharp & Dohme LLC
Eli Lilly and Company
Ono Pharmaceutical Co. Ltd
Ono Pharmaceutical Co. Ltd
Ono Pharmaceutical Co. Ltd
Servier
National University Hospital, Singapore
National Cancer Institute (NCI)
Shanghai Zhongshan Hospital
OHSU Knight Cancer Institute
Gustave Roussy, Cancer Campus, Grand Paris
Sumitomo Pharma America, Inc.